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ACRIDINE orange, 3,6-bisdimethylamino-acridine (A.O.), exhibits a variety of
effects in biological systems. It is mutagenic for Escherichia coli (Hirota, 1960;
Cuzin and Jacob, 1966), bacteriophage T4 (Orgel and Brenner, 1961), and
Drosophila melanogaster (Clark, 1953); it also inhibits tumor induction on mouse
skin in two-stage carcinogenesis (Van Duuren et al., 1969), and causes photo-
dynamic inactivation oftobacco mosaic virus (Sastry and Gordon, 1966) and other
viruses. Moreover, acridine orange has been shown to inhibit protein and nucleic
acid biosynthesis in cell culture systems (Zelenin and Liapunova, 1964; Scholtissek
and Becht, 1966).
Because of these varied properties, the mode of interaction of the dye with
nucleic acids, particularly DNA, has been widely studied by a variety of physical
methods (Van Duuren, 1969) and several modes of binding of dye to nucleic acid
have been proposed (Drummond et al., 1965).
The relationship between the mode of action of carcinogens, mutagens and
tumor-initiating agents is a problem of continuing interest (Trainin et al., 1964;
Van Duuren and Sivak, 1968). Since little is known about the tumor-initiating
and carcinogenic activity of acridine orange, it was of interest to examine these
properties in mice and rats. The present report gives the results of these
experiments.
MATERIALS AND METHODS
Animals. Mice were ICR/Ha Swiss obtained from Millerton Research Farms
(Millerton, N.Y.). Females were used in all experiments. The mice were
vaccinated against ectromelia at age 6 weeks and started on test at age 8 weeks.
All mice were housed on sterilized wood chips in metal cages, 10 to a cage. Rats
were female eastern Sprague-Dawley obtained from Blue Spruce Farms (Altamont,
N.Y.). The rats were 6 weeks old and weighed 120-125 g. when testing began.
They were housed in suspended wire mesh cages, 2 to a cage. Both mice and rats
were fed Purina Laboratory Chow and water ad libitum. The animal rooms were
temperature controlled at 22-24° C.
Biological testing methods. Animals were weighed and observed monthly for
the duration of the experiment. Tumors were recorded and counted at each
observation. Any animal judged clinically to be in poor condition was sacrificed
before the end of the experiment. All animals were examined carefully post-
mortem and tumors and other lesions were excised for histological examination.
Tissue sections were fixed in 10% formalin, blocked in paraffin and stained with
hematoxylin and eosin. Routine sections of liver were also taken in the mouse
skin treatment groups which received acridine orange repeatedly. The durationB. L. VAN DUUREN, A. SIVAK, C. KATZ AND S. MELCHIONNE
of the experiments and group sizes are given in the results section, below. Mouse
skin applications of initiator were given once only by micropipet; promoting
treatment was given three times weekly by micropipet beginning 2 weeks after
initiating treatment. The dorsal skin of the mice was shaved with an electric
small animal clipper 2 days before the first application and then as needed for the
duration of the experiment. Subcutaneous injections were given once weekly in
the left axillary area for both mice and rats with a -a inch, 26-gauge needle for
mice and a
2 inch, 23-gauge needle for rats. Mice received 0-26 mg. A.O. in
0.05 ml. of tricaprylin per injection; rats received 0 5 mg. A.O. in 0.1 ml. of
tricaprylin. For the mouse skin applications, 0-85 mg. of A.O. in 0-1 ml. acetone
was applied thrice weekly. Control groups consisted of groups receiving solvent
only, promoting agent only, initiator only, and no-treatment groups.
Acridine orange. Commercial quality hydrochloride was dissolved in 95%
ethyl alcohol-water; on addition of 0.1N sodium hydroxide, the free base was
precipitated, filtered, washed, and recrystallized from 95% ethyl alcohol-water
to give orange-brown needles, m.p. 181-182° C.
Solvents. Spectroscopic grade acetone was used for all mouse skin applica-
tions. Reagent grade tricaprylin (Eastman Kodak Company) was used for
subcutaneous injections.
Phorbol myristate acetate. The preparation of this material was described
earlier (Van Duuren and Orris, 1965).
RESULTS
The results of a series of experiments using mouse skin as the site of application
are given in TableI. In these experiments A.O. was tested as: (a) an initiating
agent, i.e. a single application of A.O. followed by repeated application of a potent
tumor-promoting agent, phorbol myristate acetate (Van Duuren and Orris, 1965);
(b) a promoting agent, i.e. a single application of 7,12-dimethylbenz(a)anthracene
(DMBA), followed by repeated application of the dye, and (c) as a skin carcinogen
by repeated application of the dye only. Appropriate control groups were
included in the experiment as shown in TableI. When tested as an initiating
agent, 3 of 40 mice bore papillomas. This is within the range of tumor incidence
TABLEI.-Application to Skin ofFemale Swiss Mice
Treatment* Number Mice with skin Days Days Median -A
A of A, to first on survival
Primary Secondary mice Papilloma Carcinoma papilloma test time
DMBA A.O. . 20
. 6 6 . 322 454 415
DMBA P.M.A. 20
. 13 5 52 449 331
A.O. P.M.A. . 40 3 0 318 473 . 467
None A.O.t 20 0 0 455 >455
DMBA Acetone 20 3 0 . 442 470 410
A.O. Acetone 20 0 0 504 >504
None P.M.A. 20 4 0 118 . 367 . 367
None Acetone 40 0 0 470 >470
None None 100 0 0 . - 526 . 469
* Primary treatment is a single application. Secondary treatment is a repeated, 3 times weekly
treatment beginning 14 days after primary treatment. Abbreviations: DMBA: 7,12-dimethyl-
benz(a)anthracene; A.O.: Acridine orange; P.M.A.: phorbol myristate acetate. Doses: DMBA,
150 pg. in 0 1 ml. acetone; A.O., 085 mg./0. 1 ml. acetone; P.M.A., 25 ,g./0- 1 ml. acetone, Acetone:
Od1ml.
t Animals with other tumors observed in this group: 1 hepatoma; 1 liver hemangioma; 1 reticulum
cell sarcoma involving liver, spleen, nodes and thymus.
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observed with the promoting agent alone (Van Duuren, 1968) so that it has to be
concluded that the mutagen acridine orange is not an initiating agent for mouse
skin. Also it is not carcinogenic for mouse skin. The most intriguing finding was
that A.O. applied repeatedly after a single dose of DMBA markedly augmented
the tumor incidence normally observed with 150 ,tg. of DMBA alone. However,
the tumors appeared late, 322 days to first papillomas.
Although not carcinogenic for mouse skin, it is noteworthy that skin applica-
tion of A.O. resulted in 3 of a total of 20 animals with liver tumors suggesting
systemic absorption through the skin.
The dye was also tested for carcinogenic activity by subcutaneous injection in
mice and rats. These results are shown in Table II.
TABLE II.-Subcutaneous Injection in Mice and Rats
Median
survival
Number of Local Days on time
Treatment animals tumors test (days)
Mice A.O.* . 30 . 1 Fibrosarcoma . 442t 420
1 Lymphocytic lym-
phoma of skin
Tricaprylin . 30 . None . 534 . 368
No treatment . 100 . None . 526 . 469
Rats A.0. . 20 . 1 Reticulum cell . 550 . 454
sarcoma
Tricaprylin . 20 . None . 550 . 537
No treatment . 30 . None . 550 . 537
* -26 mg. in 0 05 ml. tricaprylin.
t This group was terminated earlier than the others because of poor condition of animals and
severe lesions and scar tissue at the site of application.
0 O 5 mg. in 0.1 ml. tricaprylin.
In the group of 30 mice, 2 bore local tumors, a fibrosarcoma and a lymphoma;
of 20 rats only one bore a local tumor which was a reticulum cell sarcoma. No
distant tumors were observed in any of the treatment groups. In no-treatment
groups in which the median survival time was 469 days, a normal incidence (Van
Duuren et al., unpublished data) of spontaneous tumors was observed; these
tumors were lymphomas, adenomas and reticulum cell sarcomas.
DISCUSSION
In earlier studies with a series of epoxides and related compounds, we have
compared carcinogenicity and mutagenicity (Van Duuren et al., 1965). Using
data obtained from our own work and the literature, we have also compared these
two properties with tumor-initiating activity for a series of 18 diverse compounds
(Van Duuren and Sivak, 1968). No clearcut correlations could be drawn from
such comparative lists. One ofthe difficulties in making such comparisons is that
until recently mutagenicity was usually tested in microbial systems, phage or
Drosophila; whereas, carcinogenicity and tumor initiation are usually examined
in mammalian systems.
Based on the present work, acridine orange is not carcinogenic for mouse skin,
is not an initiating agent and is, at best, a borderline carcinogen by subcutaneous
injection. It has not been tested for mutagenicity in mammalian systems, but the
closely related dye, acriflavine, was tested by the dominant lethal assay in mice
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and found to be inactive (Bateman, 1966; Epstein and Shafner, 1968). Pro-
flavine, another related dye, had a low mutagenicity index in a human cell culture
system (Szybalski, 1964).
Trainin et al. (1964) described the assay of 10 mutagenic compounds for
initiating activity. The initiating agent was given by intraperitoneal injection
followed by skin application of croton oil; acridine orange was included in this
series. Of the 10 mutagens tested only urethane showed initiating activity for
mouse skin. Similar findings with other mutagens were obtained earlier by
Roe (1957).
Thus, the direct correlation between carcinogenicity and mutagenicity implied
by the somatic mutation theory ofcarcinogenesis is not fulfilled when the available
data are considered. The recent development of effective mutagenic assays in
mammalian systems should provide more definitive answers than are now available
with respect to the relationships in question (Kao and Puck, 1967).
SUMMARY
The mutagen acridine orange was tested for initiating, promoting, and carcino-
genic activity on mouse skin and for carcinogenesis by subcutaneous injection in
mice and rats. The dye is neither an initiating agent nor a carcinogen for mouse
skin. When applied on skin it induces liver tumors in mice and when given
subcutaneously in mice and rats, it induces a small number of tumors at the
injection site in both species.
Pathological diagnoses were performed by Dr. M. Baden and Dr. D. Roth
of the Department of Pathology, New York University Medical Center.
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